Skip to main content

AS/Spondyloarthritis

      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by BMS, @HorizonNews , @SanofiGenzyme,

      Dr. John Cush RheumNow

      4 years 11 months ago
      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by BMS, @HorizonNews , @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.
      RT @japaoli19: "Anatomy of the enthesis"
      #SpA #ACR20 https://t.co/uUeCWGXqtw

      Julio Gonzalez japaoli19

      4 years 11 months ago
      "Anatomy of the enthesis" #SpA #ACR20 https://t.co/uUeCWGXqtw
      RT @uptoTate: Dr. C. Bakewell reminds us that entheses can show inflammation and chronic changes. Pearl: Be sure to look

      Dr. Rachel Tate uptoTate

      4 years 11 months ago
      Dr. C. Bakewell reminds us that entheses can show inflammation and chronic changes. Pearl: Be sure to look at MSUS of the digits for enthesitis. #ACR20 #ACRbest @RheumNow https://t.co/D3nLGGv4ko
      RT @Janetbirdope: Vaccinate your pts against pneumococcal- it works! 595 vaccinated pts with RA & SpA vs 2379 nonvac

      Janet Pope Janetbirdope

      4 years 11 months ago
      Vaccinate your pts against pneumococcal- it works! 595 vaccinated pts with RA & SpA vs 2379 nonvaccinated followed to 10 yrs showed 50% less pneumonia if vaccinated even though those pts had more infections prior. Limitation not RCT & not vaccine I use @RheumNow @CRASCRRheum https://t.co/SySEL19Gcn
      Spondyloarthritis at ACR 2020: Dr. Lianne Gensler

      San Francisco-based rheumatologist Dr. Lianne Gensler examines a wide range of spondyloarthritis topics at ACR 2020, including how to join up with others interested in spondyloarthritis; enthesitis; the utility of MRI for the diagnosis for axSpA; novel treatments; and the impact of drugs on disease modification.

      RT @_connectedcare: New drug mechanisms for SpA. Nice to have expanding options
      #ACR20 https://t.co/vlTwaiuuS3

      Dr Irwin Lim _connectedcare

      4 years 11 months ago
      New drug mechanisms for SpA. Nice to have expanding options #ACR20 https://t.co/vlTwaiuuS3
      RT @drpnash: Tofacitinib for the Treatment of Adult Patients with Ankylosing Spondylitis: Primary Analysis of a Phase 3,

      Peter Nash drpnash

      4 years 11 months ago
      Tofacitinib for the Treatment of Adult Patients with Ankylosing Spondylitis: Primary Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study https://t.co/F86K1Lqou7 #tofacitinib #AS Tofa works in AS , zoster no VTE seen NNH 20(per SAE) NNT 2.5(per ASAS40)
      Inadequate Response in Spondylitis: Dr. Olga Petryna

      Dr. Petryna discusses two abstracts being presented at the ACR 2020 meeting: #0359 and #0371

      There are some really interesting poster and abstract presentations on spondyloarthritis at the ACR Convergence 2020. I’ll be covering these topics, and discussing select individual posters and abstracts during this meeting.  Here is a flavour of my read through the topics that are being covered during the meeting.  
      Non-radiographic axSpa ACR Abstracts: Dr. Rachel Tate

      Dr. Rachel Tate discusses abstracts #0876 and #0448 presented at the ACR20 annual meeting. 

      ×